Managing preclinical programs into Phase I/II clinical trials
Challenge:
A leading cancer research charity needed project management and drug development expertise to shepherd two preclinical programs into Phase I/II clinical trials. Alacrita was engaged to provide an expert resource.
Solution:
Our duties included overseeing the formal preclinical development program, submission of IND and execution of a Phase I/II clinical trial for two of the charity’s targeted therapy compounds. We were responsible for the following:
- identifying and negotiating contracts with appropriate CROs
- managing the CRO relationships
- identifying and overcoming issues as they arose
- ensuring regulatory compliance
- liaising with ethics committees
- monitoring and ensuring GMP compliance
- providing regular progress reports
Related Case Studies
Explore similar engagements and see how we've helped other clients achieve their goals.
Gene therapy preclinical, CMC, and regulatory strategy
Challenge: An early-stage biotechnology startup company reached out to Alacrita for critical support of its two lead AAV-delivered gene therapy programs. As a virtual company, the...
Interim chief medical officer for antiviral drug company
Challenge A European company developing novel antiviral drugs urgently needed an experienced pharmaceutical physician to work as an interim CMO, as the predecessor was about to...
Assessing a new inhalation device and assisting with partnering
Challenge: A medical device company has developed a nebulizer system for pulmonary delivery that can produce droplets below 1.5µm diameter. Initial clinical evaluations of...
Clinical and regulatory support for respiratory delivery specialist
Challenge: A respiratory delivery specialist company was looking at established drugs to assess the attractiveness and risks of developing inhaled or intranasal formulations of...
Interested in Learning More?
Contact us to discuss how we can support your project with similar expertise.